New hope for rare tumor patients: chemo delivered directly to desmoid growths
NCT ID NCT06268457
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with symptomatic desmoid tumors that are growing and cannot be treated with surgery or freezing. Researchers are testing a procedure that delivers chemotherapy (doxorubicin) directly into the tumor through a small tube in an artery, aiming to shrink the tumor and reduce pain. The study will follow 20 participants over time to see if this approach is safe and effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESMOID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istituto Ortopedico Rizzoli
RECRUITINGBologna, Emilia-Romagna, 40136, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New imaging method may spot tumor growth earlier after freezing treatment
- New hope for rare tumor patients: AL102 drug trial launches
- Can a Stress-Management program help young cancer patients cope?
- New Tamoxifen-Like drug tested for stubborn hormone cancers
- New drug FOG-001 takes on Hard-to-Treat cancers